How Much Did AccuTox Raise?
Funding & Key Investors

AccuTox, Inc. StatLab has successfully secured a significant capital injection, bringing its total funding to $92K. This latest financing round, which contributed $92K in substantial expansion capital, underscores the firm's robust position within the competitive diagnostic landscape. By leveraging this influx of resources, the company is well-positioned to scale its clinical operations and enhance its service delivery model across the Southeast Texas region.

What is AccuTox?

AccuTox
Healthcare ServicesMedical Laboratories & Imaging Centers

Established in 1998, AccuTox, Inc. StatLab operates as a CLIA-certified laboratory dedicated to providing high-velocity, precise blood testing services. The organization serves as a critical infrastructure partner for healthcare professionals, offering a comprehensive suite of diagnostic solutions ranging from routine health panels to complex infectious disease testing and molecular diagnostics. By prioritizing seamless integration with doctors' offices, nursing homes, and hospitals, AccuTox has carved out a specialized niche in the medical diagnostics market, focusing on affordability and operational efficiency to improve patient outcomes.

The company's commitment to timely results and diagnostic accuracy has solidified its reputation as a reliable provider in the healthcare sector. As a mature entity with over two decades of operational history, AccuTox continues to refine its laboratory workflows to meet the evolving demands of modern clinical environments, ensuring that healthcare providers have the data necessary to make informed treatment decisions.

How much funding has AccuTox raised?

AccuTox has raised a total of $92K across 1 funding round:

2021

Debt

$92K

Debt (2021): $92K with participation from PPP

Key Investors in AccuTox

PPP

Public-Private Partnership

What's next for AccuTox?

With the recent infusion of capital, AccuTox is poised to enter a new phase of strategic growth. The company is expected to focus on expanding its molecular diagnostic capabilities and potentially upgrading its laboratory infrastructure to accommodate higher testing volumes. This expansion is critical for maintaining its competitive edge in the Southeast Texas market, where demand for rapid, reliable diagnostic services remains high. Future initiatives will likely involve deepening partnerships with regional healthcare networks and investing in advanced diagnostic technologies to streamline the patient care journey. By focusing on operational scalability and technological integration, AccuTox aims to reinforce its status as a cornerstone of regional diagnostic healthcare.

See full AccuTox company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Elderly Care ServicesHealthcare ServicesOrganizationsMental Health & Rehabilitation FacilitiesNon-Profit & Charitable Organizations
Elderly Care ServicesHealthcare Services
Healthcare ServicesMental Health & Rehabilitation Facilities
Blood & Organ BanksHealthcare ServicesBusiness ServicesResearch & Development

Frequently Asked Questions Regarding AccuTox Financial Insights

What are the most recent funding rounds that AccuTox has completed, and what were the funding rounds?
AccuTox has recently completed 1 funding rounds: Debt on Mar 12, 2021.
What is the total amount of funding AccuTox has raised to date?
AccuTox has raised a total of $92K in funding to date.
How many funding rounds has AccuTox completed?
AccuTox has completed 1 funding rounds.
How much funding did AccuTox raise in its most recent funding round?
AccuTox raised $92K in its most recent funding round.
Who are the lead investors in AccuTox's latest funding round?
The lead investor in AccuTox's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in AccuTox's history?
The largest funding round in AccuTox's history was $92K.
See more information about AccuTox